CYP2C9*2 is associated with indomethacin treatment failure for patent ductus arteriosus

Genetics of the patent ductus arteriosus (PDA) and pharmacogenetics of PDA treatment

(2018) Tamorah R. Lewis et al.   Seminars in Fetal & Neonatal Medicine

Patent ductus arteriosus, its treatments, and the risks of pulmonary morbidity

(2018) Ronald I. Clyman   SEMINARS IN PERINATOLOGY

Changing patterns of patent ductus arteriosus surgical ligation in the United States

(2018) Jeff Reese et al.   SEMINARS IN PERINATOLOGY

Covariation of Neonatal Intensive Care Unit-Level Patent Ductus Arteriosus Management and In-Neonatal Intensive Care Unit Outcomes Following Preterm Birth

(2018) James I. Hagadorn et al.   JOURNAL OF PEDIATRICS

Polymorphisms in CYP2C9 are associated with response to indomethacin among neonates with patent ductus arteriosus

(2017) Caitlin J Smith et al.   PEDIATRIC RESEARCH

Trends and variation in management and outcomes of very low-birth-weight infants with patent ductus arteriosus

(2016) James I. Hagadorn et al.   PEDIATRIC RESEARCH

Surgical ligation of patent ductus arteriosus in premature infants: trends and practice variation

(2015) Jacqueline G. Weinberg et al.   CARDIOLOGY IN THE YOUNG

Comparative effectiveness and safety of indomethacin versus ibuprofen for the treatment of patent ductus arteriosus

(2015) Brian C. Gulack et al.   EARLY HUMAN DEVELOPMENT

Predictors of successful closure of patent ductus arteriosus with indomethacin

(2015) M F Ahamed et al.   Journal of Perinatology

Impact of genetic variability and treatment-related factors on outcome in early breast cancer patients receiving (neo-) adjuvant chemotherapy with 5-fluorouracil, epirubicin and cyclophosphamide, and docetaxel

(2014) C. Vulsteke et al.   BREAST CANCER RESEARCH AND TREATMENT

Hypotension following Patent Ductus Arteriosus Ligation: The Role of Adrenal Hormones

(2014) Ronald I. Clyman et al.   JOURNAL OF PEDIATRICS

Catecholamine-resistant hypotension and myocardial performance following patent ductus arteriosus ligation

(2014) S Noori et al.   Journal of Perinatology

Morbidity and mortality in preterm neonates with patent ductus arteriosus on day 3

(2013) Anna Sellmer et al.   Archives of Disease in Childhood-Fetal and Neonatal Edition

Enteral Feeding during Indomethacin and Ibuprofen Treatment of a Patent Ductus Arteriosus

(2013) Ronald Clyman et al.   JOURNAL OF PEDIATRICS

Clinical Pharmacology of Indomethacin in Preterm Infants: Implications in Patent Ductus Arteriosus Closure

(2013) Gian Maria Pacifici   PEDIATRIC DRUGS

Evidence-Based Use of Indomethacin and Ibuprofen in the Neonatal Intensive Care Unit

(2012) Palmer G. Johnston et al.   CLINICS IN PERINATOLOGY

CYP2C9 and VKORC1 polymorphisms influence warfarin dose variability in patients on long-term anticoagulation

(2012) Paulo Caleb Junior Lima Santos et al.   EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY

Genetics of Patent Ductus Arteriosus Susceptibility and Treatment

(2012) Hanine Hajj et al.   SEMINARS IN PERINATOLOGY

Intrauterine Inflammation as a Risk Factor for Persistent Ductus Arteriosus Patency after Cyclooxygenase Inhibition in Extremely Low Birth Weight Infants

(2010) Eun Sun Kim et al.   JOURNAL OF PEDIATRICS

MedEx: a medication information extraction system for clinical narratives

(2010) H. Xu et al.   JOURNAL OF THE AMERICAN MEDICAL INFORMATICS ASSOCIATION

Indomethacin Pharmacodynamics Are Altered by Surfactant: A Possible Challenge to Current Indomethacin Dosing Guidelines Created Before Surfactant Availability

(2010) Christopher McPherson et al.   PEDIATRIC CARDIOLOGY

Are Cytochrome P450 CYP2C8 and CYP2C9 Polymorphisms Associated with Ibuprofen Response in Very Preterm Infants?

(2010) Xavier Durrmeyer et al.   PLoS One

Safety and Effectiveness of Indomethacin versus Ibuprofen for Treatment of Patent Ductus Arteriosus

(2009) Lakshmi Katakam et al.   AMERICAN JOURNAL OF PERINATOLOGY

Determination of Genetic Predisposition to Patent Ductus Arteriosus in Preterm Infants

(2009) J. M. Dagle et al.   PEDIATRICS

Development of a Large-Scale De-Identified DNA Biobank to Enable Personalized Medicine

(2008) DM Roden et al.   CLINICAL PHARMACOLOGY & THERAPEUTICS